James Engelhart
Director/Board Member en Our Lady of Mercy Academy .
Perfil
El Sr. James Engelhart, CPA, es Director Financiero y Tesorero de Biohaven Pharmaceutical Holding Co. Ltd. Forma parte del Consejo de Administración de la Academia Our Lady of Mercy. Anteriormente, el Sr. Engelhart fue director ejecutivo de finanzas de Alexion Pharmaceuticals, Inc. y director de finanzas de Energizer SpinCo, Inc. y auditor de Coopers & Lybrand LLP. Se licenció en la Universidad de Villanova y se graduó en la Escuela de Negocios de Villanova.
Cargos activos de James Engelhart
Empresas | Cargo | Inicio |
---|---|---|
Our Lady of Mercy Academy | Director/Board Member | - |
Antiguos cargos conocidos de James Engelhart.
Empresas | Cargo | Fin |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director of Finance/CFO | 15/12/2021 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2016 |
ENERGIZER HOLDINGS, INC. | Corporate Officer/Principal | 01/07/2014 |
Coopers & Lybrand LLP | Corporate Officer/Principal | 01/01/1991 |
Formación de James Engelhart.
Villanova School of Business | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ENERGIZER HOLDINGS, INC. | Consumer Non-Durables |
Empresas privadas | 4 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Coopers & Lybrand LLP | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Our Lady of Mercy Academy |
- Bolsa de valores
- Insiders
- James Engelhart